Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Newsletter
Cancer Treatment, Global Warming Doublespeak and Counting All the Votes in NY
Shares of Dendreon Corp. rise as analysts look forward to new data on its experimental prostate cancer drug, Provenge. Public relations practitioners complain of scientists…
Newsletter
Cancer Drugs, Voting Rights and Cap and Trade Controversy
Author Virginia Postrel details her successful battle against breast cancer. The Justice Department re-considers whether the proposed D.C. voting rights bill is constitutional. States with…
Newsletter
Absurd Product Bans, Global Warming Legislation and Unsafe Organic Farming
Industry observers look to California to take the lead in ending the ban on online gambling. Reps. Henry Waxman and Ed Markey introduce sweeping new…
Op-Eds
Supreme Court Botches Preemption Case
SUPREME COURT BOTCHES PREEMPTION CASE…
Newsletter
Toxic Assets, NIMBYs and Fish Pedicures
Treasury Secretary Timothy Geithner unveils a plan to sell off “toxic assets” as part of the federal bank bailout. The U.S. Chamber of Commerce launches…
Op-Eds
Needle and the Damage Done
The Supreme Court botches a drug preemption case.